Alzheimer’s disease: The right drug, the right time
In the journal Science, MBI leaders Drs. Steven DeKosky and Todd Golde discuss the challenges of developing effective Alzheimer's therapies and the road ahead.
Posted in
Researchers In The Spotlight
MBI deputy director recognized for most-cited works
Dr. Steven DeKosky, M.D., was listed among the most influential authors in his field worldwide based on frequency of citations by peers.
The evolution of deep brain stimulation
Adolfo Ramirez-Zamora, M.D., associate professor of neurology, was featured in MedPage Today's Ask the Expert feature for an in-depth Q&A about deep brain stimulation.
U.S. magistrate judge credits neurosurgery team following brain surgery
Learn how neurosurgery chair Dr. Brian Hoh and his team are making an impact, from bench to bedside.
Research Snapshots: Drs. Michael Pace & David Borchelt
Study demonstrates that additional proteins misfold in the presence of neurodegenerative disease pathologies.
Drug addiction takes toll mentally, physically
Jason Hunt, M.D., assistant professor of addiction medicine, was featured as an expert source in a Citrus County Chronicle article about opioid addiction.
Genes may affect the severity of CTE
Michael Jaffee, M.D., vice chair and associate professor of neurology and director of the Trauma, Concussion and Sports Neuromedicine Program, commented about a new CTE study in The Boston Globe.
Research Snapshots: Jolie Barter & Dr. Thomas Foster
The role of epigenetics in the process of brain aging and cognitive decline.
Challenges in defining inappropriate medication use in Parkinson’s dementia
In a recent editorial in JAMA Neurology, a group of neurologists at at The Fixel Center for Neurological Diseases at UF Health discuss medication trends for Parkinson's disease dementia.
2018 Nobel Prize in Medicine: A turning point in the war on cancer
In The Conversation, Dr. Duane Mitchell discusses the importance of Drs. James Allison and Tasuku Honjo's discoveries in immunotherapy.
